While research on Mounjaro and alcohol is still being conducted, a recent large-scale analysis of patient records in Sweden showed a potential impact of a similar GLP-1 weight-loss injection, semaglutide (Wegovy), and alcohol intake
Given the medication's relatively recent approvalMounjaro in May 2022 and Zepbound in November 2023ongoing post-marketing surveillance continues to evaluate long-term safety outcomes, including potential associations with serious adverse events such as malignancy
Superior Absorption : The sulforaphane component helps your body produce and recycle more glutathione naturally, creating longer-lasting benefits
GLP-1 Medications & Hair Loss: How Studio W Salon Can Help If youre currently taking GLP-1 medications and noticing thinning hair or shedding, youre not alone
Eli Lilly is making a preemption argument, saying that the FDA approved warning labels for Trulicity and its other GLP-1 drugs, so the company cannot be held legally liable
NICE guidance (NG28) recommends considering individual factors when selecting a GLP-1 receptor agonist for type 2 diabetes